Gavrilovici Cristina, Goldsmith David J A, Reid Chris, Gubeth-Tatomir Paul, Covic Adrian
Renal Pediatric Department, St. Marry' Childrens Hospital, Iasi, Romania.
J Nephrol. 2004 Sep-Oct;17(5):642-52.
Ambulatory blood pressure monitoring (ABPM) has been developed to overcome recognized deficiencies and inaccuracies of classic (office) BP measurements in the diagnosis and management of hypertension (HTN). Although in adults it has become a valuable tool for the diagnosis and ongoing management of HTN, and its use has been documented in over 50 studies in children, few pediatric nephrologists systematically use this approach for HTN assessment. Some of the reluctance to completely embrace the technique comes from the fact that none of the major hypertension trials has been based on ambulatory BP readings. The prognostic information from ABPM studies is slowly accumulating, but there is still relatively little information on the long-term prognostic value of ABPM-derived readings. For children there are particular problems in measuring representative BP values. It would be very helpful to know to what extent ABPM can help. However, there have been few comprehensive reviews in this particular population, which leaves the practicing nephrologist rather confused. The purpose of this review is to assess the present state of knowledge of ABPM usage in children, high-lighting important studies that help to delineate the place of ABPM in their medical management. We discuss: advantages and limitations of ABPM, the variability of blood pressure in children, clinical uses of ABPM in pre-dialysis renal failure, dialysis, renal transplantation, primary renal diseases, and diabetes, comparison with adult data. The relationship between casual BP (CBP) and ABPM is presented, specifically the prevalence and relevance of either white-coat hypertension or relative 'office' hypertension. We conclude that in 2004, the sole reliance on casual BP to diagnose and to treat hypertension in children brings with it many difficulties. ABPM offers some clear solutions to these problems and thus should be routinely used in appropriately defined clinical settings, but is not a panacea.
动态血压监测(ABPM)的出现是为了克服传统(诊室)血压测量在高血压(HTN)诊断和管理中公认的不足与不准确之处。尽管在成人中,它已成为HTN诊断和持续管理的重要工具,并且在超过50项儿童研究中记录了其应用情况,但很少有儿科肾病学家系统地使用这种方法来评估HTN。对该技术不太愿意完全接受的部分原因在于,尚无任何一项主要的高血压试验是基于动态血压读数进行的。来自ABPM研究的预后信息正在缓慢积累,但关于ABPM得出的读数的长期预后价值的信息仍然相对较少。对于儿童来说,测量具有代表性的血压值存在特殊问题。了解ABPM在多大程度上能有所帮助将非常有用。然而,针对这一特定人群的全面综述很少,这让执业肾病学家相当困惑。本综述的目的是评估儿童使用ABPM的现有知识状况,突出有助于明确ABPM在其医疗管理中地位的重要研究。我们讨论了:ABPM的优点和局限性、儿童血压的变异性、ABPM在透析前肾衰竭、透析、肾移植、原发性肾脏疾病和糖尿病中的临床应用、与成人数据的比较。还介绍了偶测血压(CBP)与ABPM之间的关系,特别是白大衣高血压或相对“诊室”高血压的患病率及相关性。我们得出结论,在2004年,单纯依靠偶测血压来诊断和治疗儿童高血压存在诸多困难。ABPM为这些问题提供了一些明确的解决方案,因此应在适当界定的临床环境中常规使用,但它并非万灵药。